Sourasky Medical Center (Ichilov)
Non-Hodgkin's lymphoma treatment cost in Israel typically involves specialized care, where a bone marrow transplantation ranges from $135,000 to $240,000 and chemotherapy runs from $2,400 to $5,500. Total expenses depend on the lymphoma subtype, disease stage, and the chosen therapeutic protocol. Patients can expect 30-80% savings compared to the United States. Tel Aviv, Jerusalem, and Ramat Gan are the primary cities for this treatment.
Typical Non-Hodgkin's Lymphoma Treatment Costs in Israel
Bookimed Expert Insight: Advanced or refractory cases benefit most from centers specializing in CAR T-cell therapy and complex transplants. Sourasky Medical Center (Ichilov) reports a 90% oncology success rate with specialists like Dr. Herishanu Yair. For pediatric patients, Hadassah Medical Center is a premier choice. Dr. Polina Stepensky has performed over 3,500 transplants there, offering world-class expertise for rare blood cancers.
| Izrael | Turcja | Austria | |
| Przeszczepienie szpiku kostnego allogeniczne od dawcy spokrewnionego | od $142,000 | od $65,000 | od $150,000 |
| Przeszczep szpiku kostnego | od $135,000 | od $36,000 | od $140,000 |
| Chemioterapia w raku piersi | od $22,500 | od $1,200 | od $15,000 |
| Chemioterapia | od $2,400 | od $2,700 | od $2,500 |
| Autologiczny przeszczep szpiku kostnego | od $58,000 | od $31,500 | od $50,000 |
Dr Ram Ron jest dyrektorem Oddziału Transplantacji Szpiku Kostnego w Departamencie Onkohematologii Centrum Medycznego Sourasky.
Dr Ron Ram przeprowadził kilkaset przeszczepów komórek macierzystych, będących kluczową metodą leczenia chłoniaków nieziarniczych, w Centrum Medycznym Sourasky (Ichilov).
Dr El Hasid wykonał ponad 300 przeszczepów szpiku kostnego oraz krwi pępowinowej u dzieci. Kieruje oddziałem w Szpitalu Dziecięcym Dana Dwek.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.